See more : Credit Saison Co., Ltd. (CSASF) Income Statement Analysis – Financial Results
Complete financial analysis of Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pharmacolog i Uppsala AB (publ), a leading company in the Medical – Devices industry within the Healthcare sector.
- Hong Kong Exchanges and Clearing Limited (HKXCF) Income Statement Analysis – Financial Results
- Alphamin Resources Corp. (APH.JO) Income Statement Analysis – Financial Results
- Hamilton Thorne Ltd. (HTL.V) Income Statement Analysis – Financial Results
- Prataap Snacks Limited (DIAMONDYD.BO) Income Statement Analysis – Financial Results
- AXIM Biotechnologies, Inc. (AXIM) Income Statement Analysis – Financial Results
Pharmacolog i Uppsala AB (publ) (PHLOG-B.ST)
About Pharmacolog i Uppsala AB (publ)
Pharmacolog i Uppsala AB (publ) develops systems and solutions for use of intravenous drugs in Sweden. The company offers DrugLog, a solution for reducing errors in the drug administration process; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company was founded in 2007 and is based in Uppsala, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.94M | 10.11M | 8.82M | 1.39M | 2.18M | 1.03M | 798.33K | 13.97K | 0.00 | 0.00 |
| Cost of Revenue | 28.05M | 3.47M | 2.89M | 838.83K | 640.78K | 228.43K | -248.41K | 0.00 | -77.07K | -1.02M |
| Gross Profit | -18.11M | 6.65M | 5.93M | 546.33K | 1.54M | 806.10K | 1.05M | 13.97K | 77.07K | 1.02M |
| Gross Profit Ratio | -182.27% | 65.71% | 67.26% | 39.44% | 70.63% | 77.92% | 131.12% | 100.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 889.23K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 8.29M | 5.93M | 9.36M | 7.04M | 5.56M | 6.39M | 4.18M | 1.98M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 23.78M | 25.56M | 8.29M | 5.93M | 9.36M | 7.04M | 5.56M | 6.39M | 4.18M | 1.98M |
| Other Expenses | 0.00 | 25.76M | 11.32M | 5.80M | 7.66M | 6.07M | 5.14M | 4.76M | 3.28M | 24.76K |
| Operating Expenses | 24.34M | 25.76M | 19.61M | 11.74M | 17.02M | 13.11M | 10.70M | 11.15M | 7.46M | 2.00M |
| Cost & Expenses | 28.05M | 29.22M | 22.50M | 12.57M | 17.66M | 13.34M | 10.45M | 11.15M | 7.38M | 985.89K |
| Interest Income | 290.51K | 74.35K | 121.53K | 76.40K | 44.79K | 2.23K | 0.00 | 84.00 | 115.00 | 458.00 |
| Interest Expense | 75.00K | 129.19K | 149.17K | 147.62K | 70.18K | 86.44K | 286.50K | 104.99K | 87.01K | 71.36K |
| Depreciation & Amortization | 178.00K | 462.89K | 505.76K | -4.17M | 230.78K | 1.41M | 1.36M | 1.29M | 1.11M | 24.76K |
| EBITDA | -17.93M | -18.72M | -13.18M | -14.01M | -14.83M | -10.89M | -8.29M | -9.84M | -6.27M | -960.67K |
| EBITDA Ratio | -180.48% | -184.37% | -149.49% | -1,108.63% | -698.75% | -1,052.81% | -1,039.00% | -70,449.23% | 0.00% | 0.00% |
| Operating Income | -18.11M | -19.11M | -13.68M | -11.19M | -15.48M | -12.30M | -9.65M | -11.13M | -7.38M | -985.89K |
| Operating Income Ratio | -182.27% | -188.94% | -155.22% | -807.78% | -709.32% | -1,189.03% | -1,208.82% | -79,707.75% | 0.00% | 0.00% |
| Total Other Income/Expenses | -167.00K | -54.85K | -27.64K | -73.79K | -1.25M | -84.22K | -293.85K | -104.91K | -86.89K | -70.90K |
| Income Before Tax | -18.28M | -19.16M | -13.71M | -16.00M | -16.73M | -12.39M | -9.94M | -11.24M | -7.47M | -1.06M |
| Income Before Tax Ratio | -183.95% | -189.48% | -155.54% | -1,155.15% | -766.80% | -1,197.17% | -1,245.63% | -80,458.93% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 54.85K | 149.17K | 147.62K | 70.18K | 2.23K | 0.00 | 84.00 | 115.00 | 458.00 |
| Net Income | -18.28M | -19.22M | -13.86M | -16.15M | -16.80M | -12.39M | -9.94M | -11.24M | -7.47M | -1.06M |
| Net Income Ratio | -183.95% | -190.03% | -157.23% | -1,165.80% | -770.02% | -1,197.17% | -1,245.63% | -80,458.93% | 0.00% | 0.00% |
| EPS | -1.11 | -0.93 | -0.81 | -1.14 | -1.56 | -1.79 | -3.47 | -5.58 | -3.98 | -3.15 |
| EPS Diluted | -1.11 | -0.93 | -0.81 | -1.14 | -1.56 | -1.79 | -3.47 | -5.58 | -3.98 | -3.15 |
| Weighted Avg Shares Out | 16.41M | 20.59M | 17.07M | 14.12M | 10.77M | 6.91M | 2.87M | 2.01M | 1.88M | 335.29K |
| Weighted Avg Shares Out (Dil) | 16.41M | 20.59M | 17.07M | 14.12M | 10.77M | 6.91M | 2.87M | 2.01M | 1.88M | 335.29K |
Source: https://incomestatements.info
Category: Stock Reports